HIV Clinical Preceptorship Training (Day 1 of 2)
The HIV Clinical Training is designed to provide physicians, nurses, dental professionals, physicians assistants, nurse practitioners, pharmacists, and other working clinicians with an opportunity to do clinical observation, engage in case-based learning, and be mentored by an HIV expert in a clinical practice setting.
Important note: To receive continuing education credit, you must attend both days.
Sponsor Accreditation: The Howard University College of Medicine Office of Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education in order to provide continuing medical education for physicians.
Credits: The Howard University College of Medicine Office of Continuing Medical Education designates this educational activity for a maximum of 2.25 Credits ™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
CME Certification: To receive documentation of credits, each physician must register, sign-in, and complete and return the Record of Attendance and Program Evaluation Forms to the registration booth.
For more information, please contact Farima Camara at Farima.Camara@Howard.edu or 202-657-8532.
After completing this conference, the learner should be able to:
1. Increased knowledge of HIV/STI transmission and treatment.
2. Learn more information about sexual health advocacy
3. Increased ability to advocate for personal and community sexual and reproductive health and decrease STIGMA related effects.
COVID-19 AND HIV
1. Potential impact of COVID -19 pandemic and HIV globally
2.Disruptions to service delivery have affected 85% of HIV programs in 106 countries
3 .Lockdown impacted production and distribution of exported generic ARV medicines to countries with high HIV populous.
4 .WHO (World Health Organization predicted 6 months disruption of ART could lead to more thean 500,000 extra deaths across Africa from AIDS related illness.
HIV Medications and Drug Interactions
1.Understand the pharmacology of antiretroviral medications.
2.Identify common drug interactions for various ARV classes.
3.Identify common alternatives to known drug-drug interactions with ARV.
|VIRTUAL UPDATE AGENDA - Monday June 14, 2021 - Day 1|
12:50 pm Welcome and Introduction
Ingrid Godfrey, MPH, MidAtlantic AETC, University of Pittsburgh
Farima Camara, MPH, MidAtlantic AETC, Howard University RP
1 pm HIV & COVID-19
Charles Brown, DHA APRN/FNP-B Nurse Practitioner
|2 pm HIV 101
Anne Wiseman, LCPC
3 pm HIV & Drug Interactions
David Cornell, MBA DNP FNP AAHIVS
|4 - 4:15 pm Additional Q & A, Eval and Adjourn|
Disclosure(s)The staff and faculty involved with the planning of today’s event do not have any conflicts of interest to disclose. The MidAtlantic AIDS Education and Training Center does not endorse or recommend any commercial products, processes, or services. The representations and opinions expressed in this presentation are solely those of the author(s) and do not represent the views or policies of MA AETC, the University of Pittsburgh, or its funding agencies.
The speakers have no conflicts of interest to disclose.
Register for Day 2:
A variety of the listed topics will be discussed at this event.
- Behavioral Prevention
- HIV Transmission Risk Assessment
- Post-exposure Prophylaxis (PEP, occupational and non-occupational)
- Pre-exposure prophylaxis (PrEP)
- U=U/treatment as prevention
- Adult and adolescent antiretroviral treatment
- Antiretroviral treatment adherence, including viral load suppression
- Basic science
- Clinical manifestations of HIV disease
- HIV diagnosis (i.e. HIV testing)
- HIV monitoring and lab tests (i.e. CD4 ad viral load)
- HIV resistance testing and interpretation
- Linkage to Care
- Retention and/or re-engagement in care
- Sexually transmitted infections
- Cultural competence
- Health literacy
- Stigma or discrimination